Editor’s Memo
Peter Wehrwein
Legislation & Regulation
Richard Mark Kirkner
Anna Sinaiko
Price transparency mandates are catching on. But they may codify that which hasn’t worked all that well so far.
The Payers’ Playbook
Joseph Burns
Neeraj Sood
Employers and health insurers are asking consumers to put ‘more skin in the game’ with high-deductible health plans but don’t provide incentives for them to choose high-value care.
Tomorrow’s Medicine
Thomas Morrow, MD
Trogarzo, an anti-HIV monoclonal antibody, is an advance. But FDA approval was based on a study of only 40 people—and it had no control group.
News & Commentary

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report